Pharmafile Logo
Pharmafocus logo
Advanced Search

Lyrica to challenge antidepressants with new anxiety disorder approval

April 7, 2006
Research and Development

Pfizer's Lyrica is to go head to head with top-selling antidepressant drugs as it enters the market to treat generalised …

News

NHS lurches into new financial year with old debts and new challenges

April 7, 2006

The NHS has begun a new financial year amid considerable acrimony and massive disruption as many of its trusts grapple …

News

Novartis launch innovative leukaemia awareness campaign

March 30, 2006
Research and Development

Novartis has launched an innovative new campaign to raise awareness of leukaemia treatment among the UK's general practitioners; a move …

News

Novartis to develop Servier’s antidepressant for US

March 30, 2006
Research and Development

Novartis has signed a deal to develop and market Servier's new antidepressant and agomelatine for the US market.The drug has …

News

Novartis targets China with hepatitis drug

March 30, 2006
Research and Development

Novartis says trials of its new hepatitis drug in Chinese patients show it to be superior to standard treatment, in …

News

Taxotere approved for stomach cancer in US

March 28, 2006
Research and Development

Sanofi-Aventis has won US approval to market its drug Taxotere as a treatment for stomach cancer, and says it is …

News

Nearly half of doctors unaware of industry Code of Practice

March 28, 2006
Sales and Marketing

Nearly half of all doctors are unaware that the UK pharmaceutical industry operates a code of practice, a new survey …

News

Investigation into UK medicines prices to continue

March 24, 2006

Competition watchdog the Office of Fair Trading is to continue its investigation into how prescription medicines are priced in the …

News

Doctors oppose cuts to training budget

March 24, 2006

Doctors' leaders have spoken out against cutbacks to the medical training budget, which they warn could seriously harm patient services.The …

News

Schering backs merger with Bayer

March 24, 2006
Sales and Marketing

The management of Schering has unveiled a surprise merger deal with fellow German pharmaceutical company Bayer, in a move designed …

News

Row over cardiovascular targets in new GP contract

March 24, 2006
Research and Development

Patient groups have condemned the new GP contract, saying it ignores a potentially life-threatening condition in tens of thousands of …

News

Fast growing recruiters thrive on clinical focus

March 23, 2006
Business Services

 Recruitment company Levy Associates have become one of the UK's fastest growing companies thanks to their success in matching talented …

News

Roche goes online to co-ordinate recruitment

March 23, 2006
Medical Communications

 Roche is using a new automated system to identify the best job candidates faster, using online screening developed by technology …

News

Protelos ‘unique’ among osteoporosis treatments

March 21, 2006
Sales and Marketing

Servier says new data on its osteoporosis treatment Protelos shows it reduces women's long-term risk of bone fractures by a …

News

Whatever happened to e-marketing?

March 17, 2006
Sales and Marketing

Is e-marketing dropping off pharma marketing's radar, or are opportunities going begging? Three or four years ago, it was the …

Feature

Deal to speed UK uptake of new medicines revealed

March 17, 2006

A new deal between the UK government and the pharmaceutical industry to ensure faster and wider access to new medicines …

News

Investigators to examine Northwick Park trial safety

March 16, 2006
Research and Development

Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …

News

World’s biggest DNA project launched

March 16, 2006
Research and Development DNA, MRC, UK Biobank, Wellcome

UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …

News

Deaths reported in dementia trial

March 16, 2006
Research and Development

Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …

News

Pharma heading for collision course over cancer drug costs

March 16, 2006
Sales and Marketing

Fears that the pharmaceutical industry could be on a collision course with Europe's healthcare payers over new high priced medicines …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026